Mountain View

Eargo to Present at 10th Annual SVB Leerink Global Healthcare Conference

Retrieved on: 
Thursday, February 11, 2021

SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will present at the 10th Annual SVB Leerink Global Healthcare Conference via web cast.

Key Points: 
  • SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will present at the 10th Annual SVB Leerink Global Healthcare Conference via web cast.
  • Christian Gormsen, Eargos President and Chief Executive Officer, is scheduled to present on Friday, February 26th at 12:00PM Eastern Time.
  • Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss.
  • The companys 4th generation product, the Eargo Neo HiFi, was launched in January 2020 and features improved capabilities across audio fidelity and bandwidth.

Eargo to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

Retrieved on: 
Thursday, February 11, 2021

On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Key Points: 
  • On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.
  • The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargos website at ir.eargo.com.
  • Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss.
  • The companys 4th generation product, the Eargo Neo HiFi, was launched in January and features improved capabilities across audio fidelity and bandwidth.

WSO2 Announces Top Performing Partners for 2020

Retrieved on: 
Wednesday, February 10, 2021

Mountain View, CA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- WSO2 , the leader in digital transformation technology, announced the companys top-performing partners of 2020.

Key Points: 
  • Mountain View, CA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- WSO2 , the leader in digital transformation technology, announced the companys top-performing partners of 2020.
  • WSO2 also introduced three new awards: WSO2 Identity & Access Management Partner of the Year, WSO2 Integration Partner of the Year, and WSO2 Executives Choice.
  • In 2020, we saw our network of partners nearly double, expanding the delivery of tailored, high-performance solutions based on WSO2 technology to customers across more than 70 countries worldwide, said WSO2 Vice President of Strategy Jonathan Marsh.
  • The WSO2 Partner Program is an extensive partner network that delivers integration solutions to customers around the world and consists of Value-Added Resellers, Integration Partners, and Technology Partners.

DrChrono and Fullscript Partner to Provide Complete Solution for Integrative Practices

Retrieved on: 
Tuesday, February 9, 2021

This partnership will offer practices access to Fullscripts virtual supplement dispensary so practitioners can have a complete, functional health workspace for their integrative practice.

Key Points: 
  • This partnership will offer practices access to Fullscripts virtual supplement dispensary so practitioners can have a complete, functional health workspace for their integrative practice.
  • Now practices can seamlessly recommend practitioner-grade supplements from their clinical notes within the DrChrono platform through the free Fullscript and DrChrono integration.
  • Integrative practices can boost patient adherence with tools like supplement refill reminders and automated shipping, amplifying treatment plans.
  • Were excited to partner with DrChrono to provide practitioners with a complete workspace that allows them to dispense supplements and manage their integrative practice from a single solution, said Alan Karani, Strategic Integration Account Manager at Fullscript.

Locus Technologies receives the prestigious EBJ Award for growth and innovation for 15 consecutive years

Retrieved on: 
Tuesday, February 9, 2021

Locus received the 2020 EBJ Award for Information Technology by growing and innovating their Software as a Service (SaaS) and related services.

Key Points: 
  • Locus received the 2020 EBJ Award for Information Technology by growing and innovating their Software as a Service (SaaS) and related services.
  • Among the key drivers for Locus in 2020 was providing vital solutions to essential organizations during the earliest stages of the COVID-19 pandemic.
  • We would like to express our joy and gratitude for receiving the EBJ Information Technology award for the 15th year.
  • From 1997 Locus Technologies pioneered enterprise software-as-a-service (SaaS) for EHS Compliance, water management, and ESG credible reporting.

SMILE Becomes the Exclusive Distributor of WSO2 Products in France

Retrieved on: 
Tuesday, February 9, 2021

Paris, France and Mountain View, CA , Feb. 09, 2021 (GLOBE NEWSWIRE) -- SMILE, the European leader in digital solutions and WSO2, the leader in digital transformation technology, announced today a partnership in which SMILE is now the exclusive distributor of WSO2 products in France.

Key Points: 
  • Paris, France and Mountain View, CA , Feb. 09, 2021 (GLOBE NEWSWIRE) -- SMILE, the European leader in digital solutions and WSO2, the leader in digital transformation technology, announced today a partnership in which SMILE is now the exclusive distributor of WSO2 products in France.
  • Together through this latest agreement, SMILE and WSO2 will provide French customers with open-source, business-oriented, API-driven solutions to support their digital initiatives.
  • As a distributor for WSO2, SMILE will expand on its success as the highest selling reseller of WSO2 in France.
  • We are excited to work more deeply with SMILE as our exclusive distributor in the region.

Matt McDonough of Couchbase Recognized as 2021 CRN® Channel Chief

Retrieved on: 
Monday, February 8, 2021

The prestigious CRN Channel Chiefs list, released annually, recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth.

Key Points: 
  • The prestigious CRN Channel Chiefs list, released annually, recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth.
  • Matt McDonough brings more than a decade of experience in business development, strategy, product management, and marketing to Couchbase.
  • Matts inclusion on CRNs Channel Chiefs List for three consecutive years is a testament to his leadership and the respect he has among the channel community, said Matt Cain, President and CEO of Couchbase.
  • The 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs and partnerships.

IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day

Retrieved on: 
Friday, February 5, 2021

MOUNTAIN VIEW, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day on February 12, 2021 at 2:00 p.m.

Key Points: 
  • MOUNTAIN VIEW, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day on February 12, 2021 at 2:00 p.m.
  • Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies.
  • Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies.
  • Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

UPDATE: Developers Have Potential to Revolutionize Digital Transformation Efforts During COVID-19 Despite Challenges, Couchbase Research Finds

Retrieved on: 
Thursday, February 4, 2021

There are challenges for both organizations and developers; 86 percent of respondents experienced challenges with their development teams, including:

Key Points: 
  • There are challenges for both organizations and developers; 86 percent of respondents experienced challenges with their development teams, including:
    While developers contributions are undeniable, these challenges may still be preventing them from reaching their full potential.
  • Ultimately, if businesses can help their developers become more agile and flexible, they will find it easier to ensure they are focused in the right direction.
  • Couchbase performed its research to understand the challenges of digital transformation for developers, digital architects, and the CIO themselves.
  • Couchbase, the Couchbase logo, and the names and marks associated with Couchbases products are trademarks of Couchbase, Inc. All other trademarks are the property of their respective owners.

Developers Have Potential to Revolutionize Digital Transformation Efforts During COVID-19 Despite Challenges, Couchbase Research Finds

Retrieved on: 
Thursday, February 4, 2021

There are challenges for both organizations and developers; 86 percent of respondents experienced challenges with their development teams, including:

Key Points: 
  • There are challenges for both organizations and developers; 86 percent of respondents experienced challenges with their development teams, including:
    While developers contributions are undeniable, these challenges may still be preventing them from reaching their full potential.
  • Ultimately, if businesses can help their developers become more agile and flexible, they will find it easier to ensure they are focused in the right direction.
  • Couchbase performed its research to understand the challenges of digital transformation for developers, digital architects, and the CIO themselves.
  • Couchbase, the Couchbase logo, and the names and marks associated with Couchbases products are trademarks of Couchbase, Inc. All other trademarks are the property of their respective owners.